Dusseldorf - Delayed Quote EUR
PHAXIAM Therapeutics S.A. A (2E40.DU)
1.7720
0.0000
(0.00%)
As of March 6 at 8:13:40 AM GMT+1. Market Open.
Loading Chart for 2E40.DU
- Previous Close
1.7720 - Open
0.0000 - Bid --
- Ask --
- Day's Range
1.7720 - 1.7720 - 52 Week Range
1.6560 - 3.9300 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 13, 2025 - May 17, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 2E40.DU
View MorePerformance Overview: 2E40.DU
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
2E40.DU
46.53%
CAC 40 (^FCHI)
4.08%
1-Year Return
2E40.DU
54.91%
CAC 40 (^FCHI)
3.94%
3-Year Return
2E40.DU
77.05%
CAC 40 (^FCHI)
22.74%
5-Year Return
2E40.DU
77.05%
CAC 40 (^FCHI)
73.27%
Compare To: 2E40.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2E40.DU
View MoreValuation Measures
As of 5/5/2025
Market Cap
4.08M
Enterprise Value
-17.72M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.49
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--